Cell Based Assays Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Products & Services, By Application, By End User, By Region and Competition

Description

The Global Cell-Based Assays Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing demand for novel drugs for treating chronic diseases. The use of therapeutic drugs during various disease outbreaks, along with the growing number of research activities are two significant factors responsible for the growth of global cell-based assay market. Rising government expenditure in the healthcare sector and the rising need for toxicity screening in drugs are expected to drive market growth across different parts of the globe. Additionally, the growing demand for efficient treatment for rare diseases is further expected to increase the demand for cell-based assays, thereby fuelling market growth through 2028. Besides, growing awareness of the advantages of using new treatments along with the increasing demand to reduce the costs associated with drug discovery across the globe, are further expected to support the cell-based assays market during the forecast period. For instance, in November 2021, Menarini Silicon Biosystems, launched its CELLSEARCH, a laboratory-developed test to aid the enumeration of multiple myeloma cells using a blood sample.

Growing Demand for Cell-Based Assays Will Propel the Market Growth

Increasing demand for identification and optimization procedures for drug development is a major factor that will boost market growth during the forecast period. Growing adoption by pharmaceutical and biotechnology firms is another important factor driving the growth of this market. Furthermore, the increasing risk of disease outbreaks like swine flu, and COVID-19 and the growing rate of research activities are also expected to fuel the market growth over the years. From September 28, 2020-May 22, 2021, in the United States, 1,675 (0.2%) of 818,939 respiratory specimens tested by U.S. clinical laboratories were positive for the influenza virus. The low labor and raw material costs along with more and more CRO companies providing drug discovery services are expected to create lucrative growth during the forecast period. Increasing growth in drug discovery projects and rising adoption of strategic approaches, like collaboration with different companies for developing new drugs, will further propel the growth of the market over the years.

Increasing Number of Drug Discovery Activities Will Fuel the Market Growth

The increasing prevalence of lifestyle disorders like arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, etc., will enhance the growth of the cell-based assay market. Government organizations are investing in the research and development sector for developing new drugs for the diagnosis of chronic diseases such as cancer, diabetes, and autoimmune disorders, which is expected to create lucrative growth during the forecast period. The rising demand for novel drugs across the world for the treatment of pandemic diseases is propelling the growth of the market over the years. For instance, in May 2021, U.S. FDA granted Emergency Use Authorization (EUA) for the T-Detect COVID-19 routine T-cell test. Similarly, the rising number of research for therapeutic drug discovery and growing competition for FDA approvals among the market players is expected to create lucrative growth during the forecast period.

Market Segmentation

The global cell-based assay market can be segmented by products and services, application, end users, and region. Based on products and services, the market can be segmented into Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, and Others. Based on application, the market can be segmented into Clinical Research, Drug Discovery & Development, and Others. Based on the end user, the market can be differentiated into Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, and Contract Research Organizations. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global cell-based assays market on account of the growing demand for the identification and optimization of the novel drug in the country.

Market PlayersCorning, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group AG, Promega Corporation, F. Hoffmann-La Roche AG, Merck KGaA, Charles River Laboratories International, Inc., Menarini Silicon Biosystems, Inc. are some of the leading players operating in the Global Cell-Based Assays Market.

Recent Development

For instance, in September 2022, researchers at the Fraunhofer Institute developed Proxidrugs to utilize a cells-based waste disposal system as a potential therapeutic option for infections, cancer, and Alzheimer's disease.
For instance, in November 2021, Menarini Silicon Biosystems, launched its CELLSEARCH, a laboratory-developed test to aid the enumeration of multiple myeloma cells using a blood sample.
For instance, in August 2022, LifeNet Health LifeSciences announced the launch of its new cell-based assay services to aid in drug discovery and development.

Report Scope:

In this report, Global Cell-Based Assays Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell-Based Assays Market, By Products & Services:

Reagents
Assay Kits
Microplates
Probes & Labels
Cell Lines
Others

Cell-Based Assays Market, By Application:

Clinical Research
Drug Discovery & Development
Others

Cell-Based Assays Market, By End User:

Biotechnology & Pharmaceutical Companies
Academic & Research Institutions
Contract Research Organizations

Cell-Based Assays Market, By Region:

North America
- United States
- Canada
- Mexico

Europe
- France
- Germany
- United Kingdom
- Italy
- Spain

Asia Pacific
- China
- India
- Japan
- South Korea
- Australia

South America
- Brazil
- Argentina
- Colombia

Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Cell-Based Assays Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Product Code: 14420

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map

6. Global Cell Based Assays Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Products & Services (Reagents, Assay Kits, Microplates, Probes & Labels, Cell Lines, Others)
- 6.2.2. By Application (Clinical Research, Drug Discovery & Development, Others)
- 6.2.3. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations)
- 6.2.4. By Region
- 6.2.5. By Company (2022)
6.3. Market Map
- 6.3.1. By Products & Services
- 6.3.2. By Application
- 6.3.3. By End User
- 6.3.4. By Region

7. North America Cell Based Assays Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Products & Services
- 7.2.2. By Application
- 7.2.3. By End User
- 7.2.4. By Country
7.3. North America: Country Analysis
- 7.3.1. United States Cell Based Assays Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Products & Services
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By End User
- 7.3.2. Canada Cell Based Assays Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Products & Services
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By End User
- 7.3.3. Mexico Cell Based Assays Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Products & Services
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By End User

8. Europe Cell Based Assays Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Products & Services
- 8.2.2. By Application
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Europe: Country Analysis
- 8.3.1. France Cell Based Assays Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Products & Services
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By End User
- 8.3.2. Germany Cell Based Assays Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Products & Services
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By End User
- 8.3.3. United Kingdom Cell Based Assays Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Products & Services
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By End User
- 8.3.4. Italy Cell Based Assays Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Products & Services
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By End User
- 8.3.5. Spain Cell Based Assays Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Products & Services
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By End User

9. Asia-Pacific Cell Based Assays Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Products & Services
- 9.2.2. By Application
- 9.2.3. By End User
- 9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Cell Based Assays Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Products & Services
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By End User
- 9.3.2. India Cell Based Assays Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Products & Services
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By End User
- 9.3.3. Japan Cell Based Assays Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Products & Services
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By End User
- 9.3.4. South Korea Cell Based Assays Market Outlook
  - 9.3.4.1. Market Size & Forecast
    - 9.3.4.1.1. By Value
  - 9.3.4.2. Market Share & Forecast
    - 9.3.4.2.1. By Products & Services
    - 9.3.4.2.2. By Application
    - 9.3.4.2.3. By End User
- 9.3.5. Australia Cell Based Assays Market Outlook
  - 9.3.5.1. Market Size & Forecast
    - 9.3.5.1.1. By Value
  - 9.3.5.2. Market Share & Forecast
    - 9.3.5.2.1. By Products & Services
    - 9.3.5.2.2. By Application
    - 9.3.5.2.3. By End User

10. South America Cell Based Assays Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Products & Services
- 10.2.2. By Application
- 10.2.3. By End User
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Cell Based Assays Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Products & Services
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By End User
- 10.3.2. Argentina Cell Based Assays Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Products & Services
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By End User
- 10.3.3. Colombia Cell Based Assays Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Products & Services
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By End User

11. Middle East and Africa Cell Based Assays Market Outlook

11.1. Market Size & Forecast
- 11.1.1. By Value
11.2. Market Share & Forecast
- 11.2.1. By Products & Services
- 11.2.2. By Application
- 11.2.3. By End User
- 11.2.4. By Country
11.3. MEA: Country Analysis
- 11.3.1. South Africa Cell Based Assays Market Outlook
  - 11.3.1.1. Market Size & Forecast
    - 11.3.1.1.1. By Value
  - 11.3.1.2. Market Share & Forecast
    - 11.3.1.2.1. By Products & Services
    - 11.3.1.2.2. By Application
    - 11.3.1.2.3. By End User
- 11.3.2. Saudi Arabia Cell Based Assays Market Outlook
  - 11.3.2.1. Market Size & Forecast
    - 11.3.2.1.1. By Value
  - 11.3.2.2. Market Share & Forecast
    - 11.3.2.2.1. By Products & Services
    - 11.3.2.2.2. By Application
    - 11.3.2.2.3. By End User
- 11.3.3. UAE Cell Based Assays Market Outlook
  - 11.3.3.1. Market Size & Forecast
    - 11.3.3.1.1. By Value
  - 11.3.3.2. Market Share & Forecast
    - 11.3.3.2.1. By Products & Services
    - 11.3.3.2.2. By Application
    - 11.3.3.2.3. By End User

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

13.1. Recent Developments
13.2. Mergers & Acquisitions
13.3. Product Launches

14. Competitive Landscape

14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
- 14.6.1. Corning, Inc.
- 14.6.2. Bio-Rad Laboratories, Inc.
- 14.6.3. Thermo Fisher Scientific Inc.
- 14.6.4. Danaher Corporation
- 14.6.5. Lonza Group AG
- 14.6.6. Promega Corporation
- 14.6.7. F. Hoffmann-La Roche AG
- 14.6.8. Merck KGaA
- 14.6.9. Charles River Laboratories International, Inc.
- 14.6.10. Menarini Silicon Biosystems, Inc.